异喹啉
临床试验
医学
药理学
药品
化学
内科学
药物化学
作者
Chunying Luo,Maxwell Ampomah‐Wireko,Huanhuan Wang,Chunli Wu,Qīng Wáng,Hui Zhang,Yaquan Cao
出处
期刊:Anti-cancer Agents in Medicinal Chemistry
[Bentham Science]
日期:2020-04-24
卷期号:21 (7): 811-824
被引量:21
标识
DOI:10.2174/1871520620666200424132248
摘要
Isoquinoline analogs are an important, structurally diverse class of compounds that are extensively used as pharmaceuticals. Derivatives containing the isoquinoline scaffold have become a focus of therapeutic research because of their wide range of biological characteristics. Examples of these drugs, many of which are in clinical application or at the pre-clinical stage, are used to treat a broad swathe of ailments, such as tumors, respiratory diseases, infections, nervous system diseases, cardiovascular and cerebrovascular diseases, endocrine and metabolic diseases.Data were collected from PubMed, Web of Science, and SciFinder, through searches of drug names.At least 38 isoquinoline-based therapeutic drugs are in clinical application or clinical trials, and their chemical structure and pharmacokinetics are described in detail.The isoquinoline ring is a privileged scaffold which is often preferred as a structural basis for drug design, and plays an important role in drug discovery. This review provides a guide for pharmacologists to find effective preclinical/clinical drugs and examines recent progress in the application of the isoquinoline scaffold.
科研通智能强力驱动
Strongly Powered by AbleSci AI